Interplay of synaptic changes, neuroinflammation and beta-amyloid in cognitively normal subjects with varying risk of late-onset Alzheimer's disease (ASIC-E4)
Description of the granted funding
Early brain changes in unsymptomatic phase of Alzheimer's disease (AD) need to be characterized better, to enable successful disease modifying treatments in the future. The presence of epsilon 4-allele of Apolipoprotein E (APOE4) gene is the most important genetic risk factor for the more common late-onset AD. This study uses molecular neuroimaging and fluid-based biomarker methods to uncover the interplay of synaptic loss, neuroinflammation, amyloid deposition and structural brain changes in cognitively normal elderly volunteers with high, medium or low risk for AD due to different APOE genotype. Results provide much needed information about the presence and relationship of early biomarkers in preclinical AD. In addition, the study validates methods that could be utilized in early detection of AD pathologies, screening of study subjects and investigating effects of novel disease modifying compounds targeted against synaptic restoration and neuroinflammation in the future.
Show moreStarting year
2021
End year
2024
Granted funding
Funder
Research Council of Finland
Funding instrument
Postdoctoral Researcher
Other information
Funding decision number
341059
Fields of science
Neurosciences
Research fields
Neurotiede
Identified topics
brain, neuroscience